MAPT and Alzheimer disease: Two recent meta-analyses support determinations of the levels of Aβ42, total-tau, P-T181-tau, P-S396-tau, and NRGN in plasma NDEVs as effective diagnostic and cognitive blood biomarkers for AD [7, 16].